<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00794404</url>
  </required_header>
  <id_info>
    <org_study_id>GESPA</org_study_id>
    <nct_id>NCT00794404</nct_id>
  </id_info>
  <brief_title>Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy</brief_title>
  <acronym>EchoSpA</acronym>
  <official_title>Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy in Patients With Uncertain Diagnosis Consulting for Clinical Symptoms Suggestive of Spondylarthropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr Maria-Atonietta D'AGOSTINO</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Groupe Français d'Etude Génétique des Spondylarthropathies</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>French Society of Rheumatology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Français d'Etude Génétique des Spondylarthropathies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the interest of enthesis sonography for the
      diagnosis of spondylarthritis, in patients with uncertain diagnosis consulting for clinical
      symptoms suggestive of spondylarthritis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spondylarthritis (SPA) are the second most frequent inflammatory rheumatic disorders and,
      because it starts early in life and has a chronic progressive course, the impact of this
      disease on health resources and patient's life quality can be important. Because the
      characteritic signs of SPA, like radiological evidence of sacro-iliitis, appear late in time,
      the lag time between the onset first signs of SPA for the patient and the confirmed diagnosis
      can be very long (up to 8 years). Previous studies proved that patients who are affected by
      SPA are showing abnormal vascularization of peripheral enthesis more frequently than patients
      affected by other rheumatic diseases. Ultrasonography in B mode combined with power Doppler
      (PDUS) is a non invasive and highly sensitive toll which can detect enthesitis and abnormal
      vsacularization even for the patients who are not showing yet the evidence of SPA's
      symptomatology. Using PDUS as a early diagnosis tool could lead to the improvement of
      diagnostic procedures and therapeutic management of SpA and reduce the cost of diagnosis for
      patient and health insurances.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">489</enrollment>
  <condition>Spondylarthropathy</condition>
  <condition>Ankylosing Spondyloarthitis</condition>
  <condition>Spondyloarthritis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a symptomatology which can lead to a SPA diagnosis but with no confirmed
        diagnosis yet for any rheumatic didease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients &lt; 50 years old, consulting for spinal inflammatory symptoms &gt; 3 months
             duration

          -  patients consulting for arthritis or tenderness joints &gt; 3 months duration

          -  patients &lt; 50 years old consulting for enthesitis or dactylitis &gt; 3 months duration

          -  patients with uveitis and HLA-B27 positivity

          -  relatives of SpA patients consulting for symptoms suggestive of SpA

        Exclusion Criteria:

          -  patient with confirmed diagnosis of rheumatic disease (included SpA)

          -  patient protected by law (patient &lt;18 years old, pregnant woman)

          -  patient who can't atempt the RMI

          -  patient who will have difficulties to complete the two years of follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>D'AGOSTINO Maria-Antonietta, MCUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ambroise Paré Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ambroise Paré Hospital</name>
      <address>
        <city>Boulogne Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cavale Blanche Hospital</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cote de Nacre Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Hospital of Grenoble</name>
      <address>
        <city>Echirolles</city>
        <zip>38434</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Conception Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nancy Brabois Hospital</name>
      <address>
        <city>VANDOEUVRE les NANCY</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2008</study_first_submitted>
  <study_first_submitted_qc>November 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2008</study_first_posted>
  <last_update_submitted>October 28, 2016</last_update_submitted>
  <last_update_submitted_qc>October 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Groupe Français d'Etude Génétique des Spondylarthropathies</investigator_affiliation>
    <investigator_full_name>Dr Maria-Atonietta D'AGOSTINO</investigator_full_name>
    <investigator_title>PU-PH</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
    <mesh_term>Spondylarthropathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

